JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate
- PMID: 22753496
- PMCID: PMC3409732
- DOI: 10.1073/pnas.1209660109
JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate
Abstract
The c-Jun NH(2)-terminal kinase (JNK) signal transduction pathway is implicated in cancer, but the role of JNK in tumorigenesis is poorly understood. Here, we demonstrate that the JNK signaling pathway reduces the development of invasive adenocarcinoma in the phosphatase and tensin homolog (Pten) conditional deletion model of prostate cancer. Mice with JNK deficiency in the prostate epithelium (ΔJnk ΔPten mice) develop androgen-independent metastatic prostate cancer more rapidly than control (ΔPten) mice. Similarly, prevention of JNK activation in the prostate epithelium (ΔMkk4 ΔMkk7 ΔPten mice) causes rapid development of invasive adenocarcinoma. We found that JNK signaling defects cause an androgen-independent expansion of the immature progenitor cell population in the primary tumor. The JNK-deficient progenitor cells display increased proliferation and tumorigenic potential compared with progenitor cells from control prostate tumors. These data demonstrate that the JNK and PTEN signaling pathways can cooperate to regulate the progression of prostate neoplasia to invasive adenocarcinoma.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Comment in
-
Re: JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate.J Urol. 2013 May;189(5):1989. doi: 10.1016/j.juro.2013.01.065. Epub 2013 Jan 23. J Urol. 2013. PMID: 23594670 No abstract available.
References
-
- Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell. 2000;103:239–252. - PubMed
-
- Tournier C, et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science. 2000;288:870–874. - PubMed
-
- Lamb JA, Ventura JJ, Hess P, Flavell RA, Davis RJ. JunD mediates survival signaling by the JNK signal transduction pathway. Mol Cell. 2003;11:1479–1489. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HHMI/Howard Hughes Medical Institute/United States
- P30 DK032520/DK/NIDDK NIH HHS/United States
- R01 CA121110/CA/NCI NIH HHS/United States
- R01 CA107166/CA/NCI NIH HHS/United States
- CA065861/CA/NCI NIH HHS/United States
- P01 AI046629/AI/NIAID NIH HHS/United States
- CA107166/CA/NCI NIH HHS/United States
- F32 CA112988/CA/NCI NIH HHS/United States
- DK032520/DK/NIDDK NIH HHS/United States
- R01 CA065861/CA/NCI NIH HHS/United States
- CA121110/CA/NCI NIH HHS/United States
- CA112988/CA/NCI NIH HHS/United States
- AI046629/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous